• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗乳腺癌的流行病学、临床及组织病理学特征趋势:一项17年研究的结果

Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study.

作者信息

Afsharfard Aboulfazl, Mozaffar Mohammad, Orang Elahe, Tahmasbpour Eisa

机构信息

Department of Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran E-mail :

出版信息

Asian Pac J Cancer Prev. 2013;14(11):6905-11. doi: 10.7314/apjcp.2013.14.11.6905.

DOI:10.7314/apjcp.2013.14.11.6905
PMID:24377624
Abstract

BACKGROUND

Breast cancer (BC) is the top cancer among women worldwide and the most frequent malignancy among Iranian women over the past few decades. The increasing trend and high mortality rate of BC in the developing world necessitates studies concentrating on its characteristics in countries in Asia. The current study focused on clinical and histopathological features of BC among Iranian females.

MATERIALS AND METHODS

This retrospective study involved 714 Iranian patients with histopathologically proven BC undergoing resection of primary tumours and axillary clearance. Demographic, clinical and histopathological data were obtained and studied between ten year age groups (≤ 40 years, 41-50 years, 51-60 years, 61-70 years, and ≤ 71 years) in four chronologic phases from 1994-2009.

RESULTS

Mean age of patients was 49.4 ± 13.1 years. Most of cases (33.2%) were in 41-50 group. Mean size of primary tumors was 3.94 ± 2.47 cm and 87.1% of cases had infiltrative ductal carcinoma. Modified radical mastectomy was the most common method of surgery carried out (48.8%). Some 57.1% of tumors were in pT2 and tumor size decreased significantly during the period (p<0.05). The most common BC stage was llla (27%). Lower BC stages (0 and 1) constituted 13.9% of the diagnosed tumors. Our series of patients aged ≤ 40 had larger tumors (mean 4.73 ≤ 3.02 cm) compared to older age groups (p=0.003). Lower stages (0 and I) were more frequent among the oldest patients while nearly 50% of patients aged ≤ 40 had tumor stage III. We also observed a significant decreasing trend in the mean LN count (p<0.05) and blood vessel invasion (p=0.023) from younger to older age groups.

CONCLUSIONS

More aggressive disease for younger age groups, earlier peak incidence age and high rate of advanced BC at the time of diagnosis among Iranian women, were the main findings of this study.

摘要

背景

乳腺癌(BC)是全球女性中最常见的癌症,也是过去几十年来伊朗女性中最常见的恶性肿瘤。发展中国家乳腺癌呈上升趋势且死亡率高,因此有必要开展针对亚洲国家乳腺癌特征的研究。本研究聚焦于伊朗女性乳腺癌的临床和组织病理学特征。

材料与方法

这项回顾性研究纳入了714例经组织病理学证实患有乳腺癌且接受原发性肿瘤切除及腋窝清扫术的伊朗患者。收集了1994年至2009年四个时间阶段中十年年龄组(≤40岁、41 - 50岁、51 - 60岁、61 - 70岁和≤71岁)的人口统计学、临床和组织病理学数据并进行研究。

结果

患者的平均年龄为49.4±13.1岁。大多数病例(33.2%)在41 - 50岁年龄组。原发性肿瘤的平均大小为3.94±2.47厘米,87.1%的病例为浸润性导管癌。改良根治性乳房切除术是最常用的手术方法(48.8%)。约57.1%的肿瘤处于pT2期,在此期间肿瘤大小显著减小(p<0.05)。最常见的乳腺癌分期为Ⅲa期(27%)。较低的乳腺癌分期(0期和1期)占确诊肿瘤的13.9%。与年龄较大的组相比,我们这组年龄≤40岁的患者肿瘤更大(平均4.73≤3.02厘米)(p = 0.003)。较低分期(0期和Ⅰ期)在年龄最大的患者中更为常见,而年龄≤40岁的患者中近50%患有Ⅲ期肿瘤。我们还观察到从较年轻到较年长年龄组,平均淋巴结计数(p<0.05)和血管侵犯(p = 0.023)呈显著下降趋势。

结论

本研究的主要发现是,伊朗女性中年龄较小的组疾病侵袭性更强、发病高峰年龄更早且诊断时晚期乳腺癌的比例较高。

相似文献

1
Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study.伊朗乳腺癌的流行病学、临床及组织病理学特征趋势:一项17年研究的结果
Asian Pac J Cancer Prev. 2013;14(11):6905-11. doi: 10.7314/apjcp.2013.14.11.6905.
2
Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients.乳房切除术的比例在上升吗?对5865例患者乳房切除术与保乳治疗选择的13年趋势分析。
Ann Surg Oncol. 2009 Oct;16(10):2682-90. doi: 10.1245/s10434-009-0635-x. Epub 2009 Aug 4.
3
Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.伊朗女性乳腺癌:按年龄组、形态学及趋势划分的发病率
Asian Pac J Cancer Prev. 2016;17(3):1393-7. doi: 10.7314/apjcp.2016.17.3.1393.
4
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020).在粗针活检发现小叶肿瘤的患者中,相邻同步浸润性癌和/或导管原位癌的发生率:一项前瞻性多机构注册研究(TBCRC 020)的结果
Ann Surg Oncol. 2016 Mar;23(3):722-8. doi: 10.1245/s10434-015-4922-4. Epub 2015 Nov 5.
5
Synchronous and metachronous bilateral breast cancer: A long-term experience.同步性和异时性双侧乳腺癌:一项长期经验。
J BUON. 2018 Nov-Dec;23(6):1591-1600.
6
Histopathological features of breast cancer in Al-Madinah region of Saudi Arabia.沙特阿拉伯麦地那地区乳腺癌的组织病理学特征。
Saudi Med J. 2014 Dec;35(12):1489-93.
7
Two decades of experience with ductal carcinoma in situ of the breast in the Cancer Institute of Tehran, Iran.伊朗德黑兰癌症研究所二十年乳腺导管原位癌治疗经验
Asian Pac J Cancer Prev. 2014;15(6):2771-6. doi: 10.7314/apjcp.2014.15.6.2771.
8
Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.突尼斯中部25岁及以下非常年轻女性的乳腺癌及文献综述。
Pathol Oncol Res. 2015 Jul;21(3):553-61. doi: 10.1007/s12253-015-9944-5. Epub 2015 May 12.
9
Distinct postsurgical management in young and elderly breast cancer patients results in equal survival rates.年轻和老年乳腺癌患者不同的术后管理导致相同的生存率。
Asian Pac J Cancer Prev. 2014;15(18):7843-7. doi: 10.7314/apjcp.2014.15.18.7843.
10
Trends of breast cancer and its management in the last twenty years in Aden and adjacent governorates, Yemen.也门亚丁及周边省份过去二十年乳腺癌及其治疗的趋势。
Asian Pac J Cancer Prev. 2012;13(9):4347-51. doi: 10.7314/apjcp.2012.13.8.4247.

引用本文的文献

1
Bayesian age-period-cohort projection of cancers in Iran: a modeling study.伊朗癌症的贝叶斯年龄-时期-队列预测:一项建模研究。
BMC Cancer. 2024 Dec 18;24(1):1538. doi: 10.1186/s12885-024-13289-0.
2
Towards a New Generation of Hormone Therapies: Design, Synthesis and Biological Evaluation of Novel 1,2,3-Triazoles as Estrogen-Positive Breast Cancer Therapeutics and Non-Steroidal Aromatase Inhibitors.迈向新一代激素疗法:新型1,2,3-三唑作为雌激素阳性乳腺癌治疗药物和非甾体芳香酶抑制剂的设计、合成及生物学评价
Pharmaceuticals (Basel). 2024 Jan 9;17(1):88. doi: 10.3390/ph17010088.
3
Differences in breast cancer survival and stage by age in off-target screening groups: a population-based retrospective study.
非目标筛查组中乳腺癌生存率和分期随年龄的差异:一项基于人群的回顾性研究。
AJOG Glob Rep. 2023 Apr 11;3(2):100208. doi: 10.1016/j.xagr.2023.100208. eCollection 2023 May.
4
A dose planning study for cardiac and lung dose sparing techniques in left breast cancer radiotherapy: Can free breathing helical tomotherapy be considered as an alternative for deep inspiration breath hold?左侧乳腺癌放疗中心脏和肺部剂量 sparing 技术的剂量规划研究:自由呼吸螺旋断层放疗能否被视为深吸气屏气的替代方案?
Tech Innov Patient Support Radiat Oncol. 2023 Jan 26;25:100201. doi: 10.1016/j.tipsro.2023.100201. eCollection 2023 Mar.
5
The Effect of Neoadjuvant vs Adjuvant Chemotherapy on Final Outcome of Patients with Triple Negative Breast Cancer.新辅助化疗与辅助化疗对三阴性乳腺癌患者最终结局的影响
Med J Islam Repub Iran. 2022 Jun 8;36:61. doi: 10.47176/mjiri.36.61. eCollection 2022.
6
Predictors of the relationship between the duration of cancer and care time with the supportive care needs of patients and the quality of life of their caregivers: a path analysis.预测癌症持续时间与患者护理时间与照顾者支持性护理需求和生活质量之间关系的因素:路径分析。
Support Care Cancer. 2022 Nov;30(11):8935-8945. doi: 10.1007/s00520-022-07289-8. Epub 2022 Jul 30.
7
Age at Diagnosis of Breast Cancer in Iran: A Systematic Review and Meta-Analysis.伊朗乳腺癌诊断年龄:系统评价与荟萃分析
Iran J Public Health. 2021 Aug;50(8):1564-1576. doi: 10.18502/ijph.v50i8.6802.
8
Pre and post chemotherapy evaluation of breast cancer patients: Biochemical approach of serum selenium and antioxidant enzymes.乳腺癌患者化疗前后的评估:血清硒和抗氧化酶的生化方法
Caspian J Intern Med. 2020 Fall;11(4):403-409. doi: 10.22088/cjim.11.4.403.
9
Diagnostic Value of Elastography, Strain Ratio, and Elasticity to B-Mode Ratio and Color Doppler Ultrasonography in Breast Lesions.弹性成像、应变率、弹性与B超比值及彩色多普勒超声对乳腺病变的诊断价值
Int J Gen Med. 2020 May 25;13:215-224. doi: 10.2147/IJGM.S247980. eCollection 2020.
10
Genetic and molecular biology of breast cancer among Iranian patients.伊朗患者乳腺癌的遗传和分子生物学。
J Transl Med. 2019 Jul 8;17(1):218. doi: 10.1186/s12967-019-1968-2.